A novel vaccination approach developed by Vanderbilt Health researchers cleared the harmful gut bacterium Clostridioides difficile (C. diff) in an animal model of infection. An experimental vaccine ...

Nashville, Tenn.-based Vanderbilt Health researchers have developed a promising novel vaccine to treat Clostridioides difficile infections. Previous vaccine strategies targeted the bacterium’s primary ...

Dr. Roach: About one year ago, I had Clostridioides difficile (C. diff) that was treated with 125 mg of vancomycin for about four weeks. I had none of the usual risk factors, and the cause was never ...

BOULDER, Colo.--(BUSINESS WIRE)--Crestone, Inc. (“Crestone”) today announced positive topline results from the Phase 2 clinical trial evaluating CRS3123 in patients with Clostridioides difficile ...

HONOLULU (Island News) – The Hawaii Department of Health (DOH) has confirmed a new travel-related dengue virus case on Oahu, marking the second case in the state for 2026. Both individuals diagnosed ...

Contact Energy has lifted its first half net profit by 44% to $205 million and has outlined plans to raise $525m to spend on more renewable energy assets. The equity raise comprises an underwritten ...